Novavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing (“EUL”) to NVX-CoV2601, its updated protein-based COVID vaccine, for use in individuals aged 12 ...

Updated Sarah BranerThe premier global health authority has given Novavax’s updated COVID-19 shot a stamp of approval.The ...

Novavax, a pharmaceutical firm that created a Covid vaccine, has agreed to resolve a Class Action lawsuit and establish a $47,000,000 fund to pay back ...

Listen to this article Gaithersburg-based Novavax Inc. Tuesday announced its Nuvaxovid XBB.1.5 COVID-19 vaccine (NVX-CoV2601) ...

Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming ...

Novavax has been granted emergency use listing (EUL) by the World Health Organisation (WHO) for its updated form of the ...

"The WHO Emergency Use Listing of our updated protein-based non-mRNA COVID-19 vaccine enables expedited regulatory approvals for its 194 member states and UN procurement agencies, such as UNICEF, ...

FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants - ...

In this radio interview with John Batchelor, our conversation includes (1) the approval of the latest COVID vaccines; and (2) ...

Past doses of the COVID vaccine will not protect you against the current strains. Current available vaccines include ...

Novavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease from $735 million in the same period in 2022. The company reduced operating expenses by $950 ...

As with vaccines for other illnesses, the Center for Disease Control (CDC) highly recommends anyone over the age of five ...